```html

Genitourinary Candidiasis

What is Genitourinary Candidiasis?

Genitourinary candidiasis is a fungal infection caused primarily by Candida albicans (and, less often, other Candida species) that affects the urinary tract and the genital organs. It is most commonly referred to as “yeast infection” when it involves the vagina (vulvovaginal candidiasis) and as “candidal cystitis” when the bladder is involved. The condition can affect anyone, but women are disproportionately affected because of anatomical and hormonal factors.

The infection arises when the normal balance of microorganisms in the genital or urinary tract is disturbed, allowing Candida—normally present in small numbers as a harmless commensal—to overgrow. The result is inflammation, irritation, and a range of uncomfortable symptoms.

Common Causes

Several factors can tip the delicate microbial balance in favor of Candida growth. The most frequent contributors include:

• Antibiotic use – Broad‑spectrum antibiotics kill beneficial bacteria that keep Candida in check.
• High estrogen states – Pregnancy, hormonal contraception, and hormone replacement therapy raise estrogen, which promotes Candida adherence.
• Uncontrolled diabetes mellitus – Elevated blood glucose provides an abundant food source for yeast.
• Immunosuppression – Conditions such as HIV/AIDS, organ transplantation, or chemotherapy weaken the immune response.
• Catheterization – Indwelling urinary catheters provide a surface for biofilm formation.
• Poor genital hygiene or irritants – Tight, non‑breathable clothing, douches, scented soaps, and bubble baths can disrupt the local environment.
• Sexual activity – While not classified as an STI, sexual contact can transfer Candida between partners.
• Hormonal fluctuations – Menstrual cycle changes, especially during the luteal phase, can precipitate symptoms.
• Prolonged use of steroids – Systemic or topical steroids suppress local immunity.
• Use of spermicides or diaphragms – These products alter vaginal pH, favoring yeast growth.

Associated Symptoms

Symptoms vary depending on whether the infection is primarily genital, urinary, or both. Commonly reported complaints include:

• Intense itching, burning, or stinging in the vulva, vagina, penis, or urethra.
• Thick, white, “cottage‑cheese”‑like discharge (vulvovaginal) that may be odorless.
• Redness, swelling, and irritation of the labia or penile foreskin.
• Painful urination (dysuria) or a feeling of incomplete bladder emptying.
• Frequent urge to urinate without large volumes (urgency).
• Upper abdominal or flank discomfort if the infection ascends to the kidneys (rare).
• Sexual discomfort, including pain during intercourse (dyspareunia).
• In men, a red, tender foreskin (balanitis) or a patchy rash on the shaft.

Symptoms usually develop within a few days after the triggering factor, but chronic or recurrent cases can persist for weeks or months.

When to See a Doctor

While many mild cases clear with over‑the‑counter (OTC) treatment, you should seek professional care if you experience any of the following:

• Symptoms lasting longer than 7 days despite OTC therapy.
• Recurrent infections (≥ 4 episodes per year).
• Severe pain, swelling, or ulceration of the genital area.
• Fever, chills, or flank pain suggesting upper‑tract involvement.
• Persistent urinary symptoms (burning, urgency) after a course of antibiotics.
• Pregnancy – early evaluation is essential for safe treatment.
• Diabetes or immunocompromised status, where complications are more likely.

Prompt evaluation helps rule out other conditions (e.g., bacterial urinary tract infection, sexually transmitted infections, or dermatologic disorders) and prevents complications such as kidney infection or systemic candidiasis.

Diagnosis

Diagnosis is usually straightforward but may require laboratory confirmation in atypical or recurrent cases.

1. Medical history & physical exam – Your clinician will ask about symptom onset, sexual activity, medication use, and underlying health conditions, then inspect the genital area.
2. Microscopic analysis – A sample of vaginal discharge or urine is examined under a microscope for yeast cells and pseudohyphae.
3. Culture – Growing the organism on specialized media (e.g., Sabouraud agar) confirms Candida species and helps detect non‑albicans strains that may need different therapy.
4. Urine analysis – For suspected candidal cystitis, a mid‑stream urine sample is sent for culture. A positive result with ≥ 10⁴ CFU/mL of Candida is considered significant.
5. Additional tests – In recurrent cases, a glucose tolerance test, HbA1c, or HIV screening may be ordered to identify underlying risk factors.

Reference: Mayo Clinic. “Vulvovaginal yeast infection.” Accessed 2024.
CDC. “Candidiasis – Vaginal Yeast Infections.” 2023.

Treatment Options

Treatment aims to eradicate the overgrowth, relieve symptoms, and address predisposing factors.

Pharmacologic Therapy

• Topical azoles (clotrimazole, miconazole, tioconazole) – Creams, ointments, or suppositories applied for 3‑7 days are first‑line for uncomplicated vulvovaginal infection.
• Oral azoles – Fluconazole 150 mg single dose (or 100 mg daily for 2–3 days) is effective for both vaginal and uncomplicated urinary infections.
• Long‑acting regimens – For recurrent disease, weekly fluconazole for 6 months or an 8‑week “maintenance” protocol may be recommended.
• Echinocandins (caspofungin, micafungin) – Reserved for resistant Candida species or severe systemic disease.
• Probiotic adjuncts – Some evidence suggests Lactobacillus reuteri or L. rhamnosus may improve recurrence rates, though data are mixed.

Home & Lifestyle Management

• Keep the genital area clean and dry; change out of wet clothing promptly.
• Avoid scented soaps, douches, and feminine sprays.
• Wear breathable cotton underwear and loose‑fitting clothing.
• Limit sugar and refined carbohydrates, which can fuel yeast growth.
• Stay well‑hydrated to promote urine flow and flush microbes.
• If a urinary catheter is necessary, ensure sterile insertion technique and limit duration.

Address Underlying Conditions

Treating diabetes, adjusting hormonal therapy, or reviewing antibiotic necessity can dramatically reduce recurrence risk.

Prevention Tips

Most episodes can be avoided by maintaining a balanced microenvironment and minimizing known triggers:

• Good genital hygiene – Gently wash with warm water, pat dry, and avoid harsh chemicals.
• Smart antibiotic use – Only take antibiotics when prescribed; consider probiotic supplementation during and after a course.
• Blood‑sugar control – Aim for HbA1c < 7 % (or target set by your provider) if you have diabetes.
• Appropriate contraception – If you experience recurrent yeast infections with diaphragms or spermicides, discuss alternatives with your clinician.
• Limit moisture – Change out of swimsuits and workout gear promptly; avoid prolonged sitting in damp clothing.
• Regular medical review – Annual pelvic exams and, for high‑risk patients, periodic urine cultures can catch early colonization.
• Consider prophylactic antifungal therapy – In women with ≥ 4 episodes per year, a weekly fluconazole regimen may be advised after discussion with a healthcare provider.

Emergency Warning Signs

Key Take‑aways

Genitourinary candidiasis is a common, usually treatable fungal infection. Understanding the triggers—antibiotics, hormonal changes, diabetes, and catheter use—helps you and your healthcare team prevent recurrence. Early recognition of symptoms, appropriate testing, and prompt treatment usually lead to rapid relief. However, persistent, severe, or systemic signs warrant urgent medical evaluation.

Sources:

• Mayo Clinic. Vulvovaginal yeast infection. Accessed March 2024.
• Centers for Disease Control and Prevention. Candidiasis. Updated 2023.
• National Institutes of Health, National Library of Medicine. Treatment of recurrent vulvovaginal candidiasis. 2020.
• World Health Organization. Fungal infections – Candida. 2022.
• Cleveland Clinic. Candidiasis Overview. Accessed 2024.

```